← Evidence map

TrialCornea2023

Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1).

Elizabeth Yeu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35965392